Banff Lung Report: Current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR).

alloantibody classification systems: Banff classification clinical research/practice histocompatibility lung (allograft) function/dysfunction lung transplantation/pulmonology microarray/gene array pathology/histopathology rejection: antibody-mediated (ABMR)

Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
01 2019
Historique:
received: 05 02 2018
revised: 19 06 2018
accepted: 19 06 2018
pubmed: 30 6 2018
medline: 17 4 2020
entrez: 30 6 2018
Statut: ppublish

Résumé

The Lung session of the 2017 14th Banff Foundation for Allograft Pathology Conference, Barcelona focused on the multiple aspects of antibody-mediated rejection (AMR) in lung transplantation. Multidimensional approaches for AMR diagnosis, including classification, histological and immunohistochemical analysis, and donor- specific antibody (DSA) characterization with their current strengths and limitations were reviewed in view of recent research. The group also discussed the role of tissue gene expression analysis in the context of unmet needs in lung transplantation. The current best practice for monitoring of AMR and the therapeutic approach are summarized and highlighted in this report. The working group reached consensus of the major gaps in current knowledge and focused on the unanswered questions regarding pulmonary AMR. An important outcome of the meeting was agreement on the need for future collaborative research projects to address these gaps in the field of lung transplantation.

Identifiants

pubmed: 29956477
doi: 10.1111/ajt.14990
pii: S1600-6135(22)08895-5
doi:

Substances chimiques

Antibodies 0
Complement C4 0
HLA Antigens 0
Isoantibodies 0
Peptide Fragments 0

Types de publication

Congress

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-31

Informations de copyright

© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Auteurs

A Roux (A)

Pneumology, Adult CF Center and Lung Transplantation Department, Foch Hospital, Suresnes, France.
Paris Translational Research Center for Organ Transplantation, French National institute of Health and Medical Research (INSERM). Unit UMR S970, Paris, France.
Versailles Saint-Quentin-en-Yvelines University, UPRES EA 220, Suresnes, France.

D J Levine (DJ)

Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.

A Zeevi (A)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

R Hachem (R)

Washington University, School of Medicine Division of Pulmonary & Critical Care, St. Louis, MO, USA.

K Halloran (K)

Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

P F Halloran (PF)

Alberta Transplant Applied Genomics Center, University of Alberta, Edmonton, Alberta, Canada.

L Gibault (L)

Department of Pathology, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

J L Taupin (JL)

Department of Immunology and Histocompatibility, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

D A H Neil (DAH)

Department of Pathology, Queen Elizabeth Hospital, Birmingham, UK.

A Loupy (A)

Paris Translational Research Center for Organ Transplantation, French National institute of Health and Medical Research (INSERM). Unit UMR S970, Paris, France.

B A Adam (BA)

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.

M Mengel (M)

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.

D M Hwang (DM)

Toronto Lung Transplant Program, University Health Network, University of Toronto, Ontario, Canada.

F Calabrese (F)

Department of Cardio-Thoracic and Vascular Sciences, Pathology Section, University of Padova, Italy.

G Berry (G)

Department of Pathology, Stanford University, Stanford, CA, USA.

E N Pavlisko (EN)

Department of Pathology, Duke University Hospital, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH